Allegiant Private Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$5.8M Buy
35,197
+571
+2% +$94.5K 0.94% 32
2021
Q1
$5.69M Buy
34,626
+262
+0.8% +$42.4K 1.04% 32
2020
Q4
$5.41M Buy
+34,364
New +$5.07M 1.12% 22

Other funds holding JNJ

Allegiant Private Advisors's JNJ Position: Q2 2021 in Review

Allegiant Private Advisors increased its Johnson & Johnson (JNJ) stake by 1.6% in Q2 2021, buying an estimated $94.5K and bringing the position to 35,197 shares worth $5.8M. The position accounts for 0.94% of the portfolio, ranked #32.

Allegiant Private Advisors first reported a position in JNJ in Q4 2020 and has held it in 3 quarters since. 3,324 funds tracked by Wall St. Rank hold JNJ as of Q2 2021.

  • Allegiant Private Advisors held 35,197 shares of Johnson & Johnson worth $5.8M as of Q2 2021.
  • Allegiant Private Advisors bought 571 Johnson & Johnson shares in Q2 2021, an estimated $94.5K.
  • Johnson & Johnson made up 0.94% of Allegiant Private Advisors's portfolio in Q2 2021, its #32 holding.
  • Allegiant Private Advisors first reported a position in Johnson & Johnson in Q4 2020 and has held it in 3 quarters since.
  • 3,324 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2021.

Based on Allegiant Private Advisors's 13F filing for Q2 2021, filed 7 Jul 2021.